CARLSBAD, Calif.– Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on developing its excimer laser system to treat vascular diseases, announces the United States Patent and Trademark Office has granted the company a patent for liquid-filled laser ablation catheters with expanded distal optical windows. U.S. patent 11,284,941 (the ’941 patent), titled Laser Ablation Catheters Having Expanded Distal Tip Windows for Efficient Tissue Ablation, describes a catheter with an increased ablation surface area at the distal catheter tip. This is the 11th U.S. patent issued to Ra Medical and is a natural evolution in the patent coverage of the company’s DABRA technology.
“The design covered by this patent is important because it allows us to achieve an increased ablation area without increasing the overall catheter profile. We believe this will make it easier for us to develop a family of products to address larger diameter vessels using the same base platform technology. The patent marks another milestone in our intellectual property strategy to fortify our competitive position both now and in the future,” said Will McGuire, Ra Medical Systems CEO.
